Miguel Sampedro-Nuñez, Aura Dulcinea Herrera-Martínez, Alejandro Ibáñez-Costa, Esther Rivero-Cortés, Eva Venegas, Mercedes Robledo, Rebeca Martínez-Hernández, Araceli García-Martínez, Joan Gil, Mireia Jordà, Judith López-Fernández, Inmaculada Gavilán, Silvia Maraver, Montserrat Marqués-Pamies, Rosa Cámara, Carmen Fajardo-Montañana, Elena Valassi, Elena Dios, Anna Aulinas, Betina Biagetti, Cristina Álvarez Escola, Marta Araujo-Castro, Concepción Blanco, Paz de Miguel, Rocío Villar-Taibo, Clara V Álvarez, Sonia Gaztambide, Susan M Webb, Luis Castaño, Ignacio Bernabéu, Antonio Picó, María-Ángeles Gálvez, Alfonso Soto-Moreno, Manel Puig-Domingo, Justo P Castaño, Mónica Marazuela, Raúl M Luque
INTRODUCTION: Growth-hormone (GH)-secreting pituitary-tumors (GHomas) are the most common acromegaly cause. At diagnosis, most of them are macroadenomas, and up to 56% display cavernous sinus invasion. Biomarkers assessment associated with tumor-growth and invasion are important to optimize their management. OBJECTIVES: To identify clinical/hormonal/molecular-biomarkers associated with tumor-size and invasiveness in GHomas, and to analyze the influence of pre-treatment with somatostatin-analogs or dopamine-agonists in key molecular biomarkers expression...
May 3, 2024: European Journal of Endocrinology